20152019
If you made any changes in Pure these will be visible here soon.

International and National Collaboration Publications and projects within past five years.

Publications 2015 2019

Maksaportin sappitiesyöpä eli Klatskinin tuumori

Sallinen, V., Peltola, K. & Mäkisalo, H., 2019, In : Duodecim. 135, 6, p. 599-607 9 p.

Research output: Contribution to journalReview ArticleScientificpeer-review

Hyponatremia associates with poor outcome in metastatic renal cell carcinoma patients treated with everolimus: prognostic impact

Penttilä, P., Bono, P., Peltola, K. & Donskov, F., 2 Nov 2018, In : Acta Oncologica. 57, 11, p. 1580-1585 6 p.

Research output: Contribution to journalArticleScientificpeer-review

Neoadjuvant therapy offers longer survival than upfront surgery for poorly differentiated and higher stage pancreatic cancer

Nurmi, A-M., Mustonen, H., Parviainen, H., Peltola, K., Haglund, C. & Seppänen, H., 2018, In : Acta Oncologica. 57, 6, p. 799-806 8 p.

Research output: Contribution to journalArticleScientificpeer-review

Quality of Life Outcomes for Cabozantinib Versus Everolimus in Patients With Metastatic Renal Cell Carcinoma: METEOR Phase III Randomized Trial

Cella, D., Escudier, B., Tannir, N. M., Powles, T., Donskov, F., Peltola, K., Schmidinger, M., Heng, D. Y. C., Mainwaring, P. N., Hammers, H. J., Lee, J. L., Roth, B. J., Marteau, F., Williams, P., Baer, J., Mangeshkar, M., Scheffold, C., Hutson, T. E., Pal, S., Motzer, R. J. & 1 othersChoueiri, T. K., 10 Mar 2018, In : Journal of Clinical Oncology. 36, 8, p. 757-+ 11 p.

Research output: Contribution to journalArticleScientificpeer-review

Angiotensin Inhibitors as Treatment of Sunitinib/Pazopanib-induced Hypertension in Metastatic Renal Cell Carcinoma

Penttila, P., Rautiola, J., Poussa, T., Peltola, K. & Bono, P., Jun 2017, In : Clinical Genitourinary Cancer. 15, 3, p. 384-390 7 p.

Research output: Contribution to journalArticleScientificpeer-review

Open Access
File

Press / Media

Minulla todettiin: Levinnyt munuaissyöpä

Katriina Peltola

25/12/2016

1 media contribution

Press/Media: Press / Media